New England Journal of Medicine , 384 (11), 9891002.
For example, one analysis found that patients taking a GLP-1 drug had a 3.67 times higher risk of gastroparesis compared to patients who took bupropion-naltrexone, a different weight-loss drug
Pills are also easier to manufacture than injectable pens, which could help avoid the frustrating supply problems that slowed earlier GLP-1 launches
Things to Keep in Mind Wegovy is preferred on most Aetna plans CVS Caremark made it their primary GLP-1 in July 2025 Prior authorization is required you'll need to meet BMI and documentation criteria If denied, file an appeal 65%+ of appealed denials are overturned when properly documented [5] Cardiovascular benefit strengthens your case Wegovy is FDA-approved to reduce heart attack/stroke risk (March 2024) If your PA is denied, don't give up most denials can be overturned with the right documentation
FGF, Fibroblast growth factor
Gy nn hng lot cc bnh l v da khin bn lo lng